Zoetis Inc. (ZTS) to Issue Quarterly Dividend of $0.53 on June 2nd

Zoetis Inc. (NYSE:ZTS) declared a quarterly dividend on Thursday, February 5th. Stockholders of record on Monday, April 20th will be given a dividend of 0.53 per share on Tuesday, June 2nd. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, April 20th.

Zoetis has raised its dividend by an average of 0.2%per year over the last three years and has raised its dividend every year for the last 14 years. Zoetis has a dividend payout ratio of 31.0% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Zoetis to earn $6.75 per share next year, which means the company should continue to be able to cover its $2.12 annual dividend with an expected future payout ratio of 31.4%.

Zoetis Trading Up 0.5%

Shares of NYSE:ZTS opened at $127.40 on Friday. The company has a market capitalization of $56.14 billion, a PE ratio of 21.45, a P/E/G ratio of 2.19 and a beta of 0.96. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. Zoetis has a 12-month low of $115.25 and a 12-month high of $177.00. The business’s fifty day simple moving average is $123.96 and its 200-day simple moving average is $136.41.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. Zoetis’s revenue was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.58 earnings per share. As a group, equities research analysts predict that Zoetis will post 6.07 earnings per share for the current fiscal year.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.